Sep 30, 2010

United Therapeutics Q3 2010 Earnings Report

Total Revenue
$171M
Previous year: $97.2M
+75.9%
EPS
$0.71
Previous year: $0.22
+222.7%
Gross Profit
$149M
Previous year: $84.5M
+76.7%
Cash and Equivalents
$210M
Previous year: $135M
+56.3%
Free Cash Flow
$98.7M
Previous year: -$8.07M
-1323.9%
Total Assets
$1.28B

United Therapeutics

United Therapeutics